Prof Kjetil Tasken speaking about the cost of CAR T-cells therapy and inequalities in cancer treatment
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment
Prof. Magnus Essand, of Uppsala University, joined us for our Virtual Panel Discussion on December 17th.
During our Virtual Panel Series discussion on December 17th, our expert panellist’s discussed, Immuno-oncology….
Prof. Ann Ager, of Cardiff University, speaks about the development of CAR-T Cells Read More »
Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about the next steps that need to be taken for clinical trials to progress
Dr. Capucine Baldini, of Gustave Roussy, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic.
Eibhlin Mulroe spoke to PMF about the difficulties of performing clinical trials in hospitals during the first and second wave of the pandemic.
Dr Capucine Baldini, Medical Oncologist, Drug Development (DITEP), Institut de Cancérologie Gustave Roussy, will be joining us for our next Virtual Panel Series
PMF Interviews Dr. Capucine Baldini, of Gustave Roussy Read More »
Prof. Rob Jones gives us insight into the work being done at Cancer Research UK Glasgow Clinical Trials Unit
PMF Interviews Professor Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit Read More »
Dr. Julien Masliah Planchon, of Institut Curie, gave interesting insight into Institut Curie’s use of Molecular Tumour Boards.
Dr. Julien Masliah Planchon speaks about Institut Curie’s use of Molecular Tumour Boards Read More »
Dr. Maud Kamal, of Institut Curie, joined us for our Virtual Panel Series discussions on November 12, 2020